GlassScriptPhysician profile
Kirk D Jenkins
NPI 1306161955
$9,203.47
in general payments reported to CMS, 2019-2025
18 companies · $1,281 in 2025
The $1,281 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $267 · 2021: $546 · 2022: $981 · 2023: $745 · 2024: $4,895 · 2025: $1,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,392 · Food and Beverage: $3,151 · Travel and Lodging: $223 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,392.00 |
| Food and Beverage | $3,150.83 |
| Travel and Lodging | $223.44 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,358.95 | 2019-2025 | |
| Amgen INC. | $811.36 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Janssen Biotech, INC. | $726.43 | 2019-2025 | Tremfya, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $246.00 | 2019-2025 | Orencia |
| Novartis Pharmaceuticals Corporation | $228.13 | 2019-2025 | |
| Horizon Therapeutics Plc | $125.00 | 2020 | |
| Lilly USA, LLC | $118.26 | 2019-2024 | Taltz |
| Ucb, INC. | $112.28 | 2019-2025 | Bimzelx |
| Glaxosmithkline, LLC. | $93.17 | 2019-2025 | Benlysta |
| Sandoz INC. | $92.61 | 2023-2024 | Hyrimoz |
| Sobi, INC | $71.47 | 2023-2025 | |
| Novo Nordisk INC | $69.02 | 2022 | |
| Pfizer INC. | $56.25 | 2019-2022 | |
| Celgene Corporation | $23.62 | 2019 | |
| Genentech USA, INC. | $22.26 | 2025 | Actemra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $19.45 | 2025 | |
| Endo Pharmaceuticals INC. | $14.91 | 2019 | |
| Medexus Pharma, INC. | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirk Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.